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Abstract
Melatonin modulates many important functions within the eye by interacting with a family of G-protein-coupled receptors
that are negatively coupled with adenylate cyclase. In the mouse, Melatonin Receptors type 1 (MT1) mRNAs have been
localized to photoreceptors, inner retinal neurons, and ganglion cells, thus suggesting that MT1 receptors may play an
important role in retinal physiology. Indeed, we have recently reported that absence of the MT1 receptors has a dramatic
effect on the regulation of the daily rhythm in visual processing, and on retinal cell viability during aging. We have also
shown that removal of MT1 receptors leads to a small (3–4 mmHg) increase in the level of the intraocular pressure during
the night and to a significant loss (25–30%) in the number of cells within the retinal ganglion cell layer during aging. In the
present study we investigated the cellular distribution in the C3H/f
+/+ mouse retina of MT1 receptors using a newly
developed MT1 receptor antibody, and then we determined the role that MT1 signaling plays in the circadian regulation of
the mouse electroretinogram, and in the retinal dopaminergic system. Our data indicate that MT1 receptor
immunoreactivity is present in many retinal cell types, and in particular, on rod and cone photoreceptors and on
intrinsically photosensitive ganglion cells (ipRGCs). MT1 signaling is necessary for the circadian rhythm in the photopic ERG,
but not for the circadian rhythm in the retinal dopaminergic system. Finally our data suggest that the circadian regulation of
dopamine turnover does not drive the photopic ERG rhythm.
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Introduction
Previous studies have shown that melatonin is synthesized in the
eyes of most vertebrates, where it is believed to modulate many
important functions [1]. Melatonin exerts its influence by
interacting with a family of G-protein-coupled receptors that are
negatively coupled with adenylate cyclase [2]. In humans,
immunoreactivity to melatonin receptor type 1 (MT1) has been
located at the photoreceptors, in the inner retinal neurons and on
ganglion cells (GCs) [3]. In the mouse, MT1 mRNAs have been
localized to photoreceptors, inner retinal neurons, and GCs [4].
Thedistributionofexpressionsuggeststhat MT1 receptorsmayplay
an important role in retinal physiology. However, since the vast
majority of mouse strains are genetically incapable of synthesizing
melatonin in the pineal and retina [5,6], the effects of melatonin
receptor removal on retinal physiology in melatonin-proficient and
melatonin-deficient mice are not well understood. Our laboratory
has recently produced mice with a targeted deletion of the MT1
receptor gene in a melatonin proficient background (C3H/f
+/+) [4]
and we have reported that absence of the MT1 receptors has a
dramatic effect on the regulation of the daily rhythm in visual
processing, and on retinal cell viability during aging [4].
Furthermore, we have also shown that absence of MT1 receptors
leads to a small (3–4 mmHg) increase in the level of intraocular
pressure during the night, and to a significant loss (25–30%) in the
number of cells within the retinal GC layer during aging [7].
Previous studies have reported that in C57/Bl6 mice, only the
photopic electroretinogram (ERG) is under circadian control,
whereas the scotopic ERG is not regulated by the circadian clock
[8,9]. However, since these experiments were performed in
melatonin-deficient mice (C57/Bl6), it possible that the lack of
circadian regulation in the scotopic ERG may be due to the lack of
melatonin signaling. Earlier work has demonstrated that melato-
nin modulates retinal dopamine release [10], and retinal
dopamine content and metabolism are circadian in mice that
rhythmically synthesize melatonin, including C3H/f
+/+ mice, but
not in mice that are genetically incapable of synthesizing
melatonin [6,11–12]. In melatonin-deficient mice, a circadian
rhythm of dopamine metabolism can be induced by daily
injections of melatonin [12], and recent findings suggest that
melatonin in the mouse retina may contribute to circadian
rhythms of protein phosphorylation in photoreceptors [13].
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24483The aim of the present study was to further investigate the
cellular distribution of MT1 receptors using a newly-developed
MT1 receptor antibody, and then to determine the role that MT1
signaling plays in the circadian regulation of the mouse ERGs and
in the retinal dopaminergic system. Our data indicate that MT1
receptor immunoreactivity is present in many retinal cell types,
and MT1 signaling is necessary for the circadian rhythm in the
photopic ERG, but not for the circadian rhythm in the retinal
dopaminergic system.
Results
MT1 immunoreactivity in the mouse retina
Western blotting of the MT1 receptor in the mouse retina
showed an immunoreactive band of about 40 kDa in the retina of
the WT, but not in the MT1
2/2 mice (Figure 1, Top). The control
blots, which were treated with primary antibody pre-absorbed
with the antigen blocking peptide, or using retina from MT1
2/2
mice did not show any band around 40 kDa. A band of
approximately 80 kDa was also present in WT. (Figure 1, Top).
Immunocytochemistry using the anti- MT1 antibody identified a
strong and specific immunoreactivity in the inner/outer segment
of the photoreceptors, and in the GC layer; a weak immunore-
activity was also observed in the outer plexiform layer (Figure 1A–
C, Bottom). The immunoreactivity was completely abolished by
pre-incubation of the antibody with the blocking peptide (Figure 1
D, E), and was absent in the retina obtained from MT1
2/2 mice
(Figure 1 F, G). We then investigated whether MT1 immunore-
activity was present on rods and cones by double labeling using a
rhodopsin antibody and peanut agglutinin, a well-established
marker for the cone matrix sheaths of cones. As shown in Figure 2,
MT1 immunoreactivity was present on the rod photoreceptors
(Figure 2 A–C), and on the cones (Figure 2 D–F). Finally, we
investigated whether MT1 immunoreactivity was also present on
the intrinsically photosensitive GCs (ipRGCs). As shown in Figure 3
A–C, we detected MT1 immunoreactivity on ipRGCs as indicated
by the colocalization of MT1 and melanopsin immunoreactivity
(Figure 3C).
MT1 receptors control the circadian rhythm of the photic ERG. WT mice
did not show any circadian regulation in the scotopic ERGs
(Figure 4 A–B; Two-Way ANOVA, P.0.1), whereas the photopic
ERG in WT mice showed a clear circadian regulation (Figure 4 C,
Two-Way ANOVA, P,0.01). The circadian regulation of the
photopic ERG was absent in MT1
2/2 mice (Figure 4 D, Two-
Way ANOVA, P.0.1).
Effect of MT1 removal on the retinal dopaminergic
system
The effect of MT1 removal on the dopaminergic system was
determined by counting the number of TH-positive neurons, and
by investigating the circadian regulation of DA and DOPAC
levels. As reported in Figure 5A, the number of TH-positive
neurons in the retina of WT mice was not different from the
number observed in MT1
2/2 (WT=559.3+/244.3; MT1
2/2
569+/250.4, N=3 for each genotype; t-test, P.0.1; Figure 4A).
The level of DA and DOPAC were circadian in WT and MT1
2/2
mice (Two-way ANOVA, P,0.05 Figure 5 B–C;), and no
differences were observed in the levels of DA and DOPAC
between the WT and MT1
2/2 (Tukey Tests, P.0.05).
Discussion
The focus of this study was to investigate the distribution of
MT1 receptors in the retina using a newly developed antibody,
and to determine the effects of MT1 signaling removal on the
circadian regulation of the mouse ERGs and on the retinal
dopaminergic system. Our data indicated that the newly
developed MT1 receptor antibody detected in mouse an
immunoreactive band of about 40 kDa in the retina of the WT,
but not in the MT1
2/2, or in control blots incubated with primary
antibody pre-absorbed with the antigen blocking peptide (Figure 1).
The data obtained are consistent with previously published reports
in chicken, rat, and human, which indicated that MT1 receptor
has a molecular weight around 40 kDa [14–16]. The fact that a
band around 80 kDa was detected in the retinal extract of WT
mice is intriguing and deserves some discussion. Previous studies
have reported that melatonin receptors have the potential to form
heteromeric complexes and these receptors were indeed among
the first G protein-coupled receptors that have been shown to
homo- and heteromerize in a constitutive manner when
transfected in HEK 293 cell at physiological levels [2]. Therefore,
it is possible that the band observed at 80 kDa may represent the
MT1 receptor in the homodimeric or heteromeric form. However,
it important to mention that a very weak band of approximately
80 kDa was also present in the blot treated with the blocking
peptide and in the blot of retinal extract from MT1
2/2 mice.
Figure 1. MT1 receptor immunoreactivity in the mouse retina. A
band corresponding to the molecular weight of approximately 40 kDa
was observed in western blotting of retinal extract from WT mice. No
band was observed when the blot was treated with antibody pre-
absorbed with the blocking peptide. A band of approximately 80 kDa
was also present in retinal extract from WT mice. A very faint band
around 80 kDa was also present the blot treated with the blocking
peptide and in the blot of retinal extract from MT1
2/2 mice. a-Tubulin
expression at the molecular weight of 53 kDa is also shown.
Ab=Melatonin receptor 1 antibody; BP=blocking peptide. Similar
results have been obtained for at least 3 independent samples for each
experimental condition (Top panel). MT1 immunoreactivity was
localized in the outer segments of the photoreceptors (A, B), and in
the ganglion cells (A, C), while a weak signal is observed in the outer
plexiform layer (A, white arrows). No signal was detected in the outer
segments or in ganglion cells using the blocking peptide (D, E) or in
retina obtained from MT1
2/2 mice (F, G). OS=outer segments; IS=inner
segments; ONL=outer nuclear layer; INL=inner nuclear layer; GCL
=ganglion cell layer. Micrographs are representative of results obtained
from at least four animals for each experimental condition (Bottom
panel).
doi:10.1371/journal.pone.0024483.g001
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non-specific binding of the MT1 receptor antibody. Additional
studies will be required to resolve this important issue.
The data obtained with immunocytochemistry (ICCH) are also
consistent with previously published data using in situ hybridization
in the mouse [4] or with ICCH in rat and human [2,3,15], which
showed that MT1 receptors are widely distributed within the
retina. Our study expands on these previous reports by showing
that MT1 receptors are located on the rod, and possibly the cone
photoreceptors (Figure 2). The fact that MT1 receptors are present
on the photoreceptors further supports our previous study where
we reported that MT1 signaling is an important modulator of
photoreceptor functions and viability [4]. Previous studies have
also shown that melatonin is synthesized in the photoreceptors
[17–18], and its synthesis is directly controlled by the circadian
clock [18–19]. The fact that MT1 receptors are expressed on the
cells responsible for its synthesis suggests that melatonin plays an
autocrine role within the photoreceptors, and on the circadian
clock located in these cells. A previously published study reported
that ipRGCs express dopamine receptors [20], and our new data
Figure 2. MT1 receptor immunoreactivity in photoreceptor cells. MT1 immunoreactivity was localized with rod outer-inner segments
(A=MT1; B=rhodopsin; C=merge) and to cones outer-inner segments (D=MT1; E=peanut agglutinin; F=merge) and to a lesser extent, to the
pedicles of the cones. The co-localization of MT1 receptor signal with rods or cones is evident in panels B and C, respectively, where the images have
been merged. The bars at the bottom of the Figures represent 10 mm. Micrographs are representative of results obtained from at least three mice.
doi:10.1371/journal.pone.0024483.g002
Figure 3. MT1 receptor immunoreactivity in ipRGCs cells. The co-localization of MT1 receptor with melanopsin immunoreactivity on ipRGCs is
evident in panel C (white arrows) where the images have been merged. (A=MT1; B=melanopsin; C=merge). The bars at the bottom of the Figures
represent 15 mm. Micrographs are representative of results obtained from at least three mice.
doi:10.1371/journal.pone.0024483.g003
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PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24483Figure 4. Quantification of the scotopic and photopic ERGs of WT and MT12/2 mice recorded after 18 (CT 6) and 30 (CT18) h in DD.
No differences in the amplitude of the a- and b-wave were observed in the scotopic ERGs of WT mice (A, B). The photopic ERGs show a circadian
regulation in WT (C, Two-way ANOVA, P,0.01, N=6–8 for each time-point) but not in MT1
2/2 mice (D, Two-way ANOVA, P.0.1, N=6–8 for each
time-point). White Circles=CT6; Black circles=CT 18.
doi:10.1371/journal.pone.0024483.g004
Figure 5. Number of TH-positive cells in the retina of WT and MT1
2/2 (A) and DA and DOPAC levels measured in WT and MT1
2/2 in
DD. A) The number of TH-positive neurons in the retina of WT was not different from the number observed in MT1
2/2 (t-test, P.0.1). The level of DA
(B) and DOPAC (C) decreased as expected from day to night in both genotypes (WT: white circles; MT1
2/2: black circles), and no differences were
observed in mean levels of DA and DOPAC at each time-point between the WT and MT1
2/2(Two-way ANOVA, P,0.05 in both cases). N=9–12 for
each point and genotypes.
doi:10.1371/journal.pone.0024483.g005
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are also present on the ipRGCs (Figure 3). Such a result would
suggest that the melatonin-dopamine feedback loop [21] which
regulates the rods and cones circadian physiology may be also
involved in the modulation of circadian rhythms in the ipRGCs.
Our previous study had shown that melatonin via MT1 actually
controls the rhythms of the scotopic and photopic ERGs in C3H
mice, when the mice are kept in a 12 h light: 12 h dark cycle [4],
and other investigations performed with melatonin-deficient mice
haveshownthat theamplitudeofthescotopicERGsis not rhythmic
in mice housed in constant conditions (i.e., constant darkness), and
thus demonstrating that the scotopic ERGs are not under circadian
control [8,9]. Since melatonin is believed to be a key regulator of
circadian functions within the retina [21], we decided to investigate
whether the scotopic ERG was under circadian regulation in a
melatonin-proficient mouse. As shown in Figure 4 A–B the scotopic
ERGs did not show any circadian regulation in our mice. On the
other hand, a circadian rhythm in the photopic ERGs was observed
in WT mice [Figure 4C], and was also observed in melatonin-
deficient mice [8,9] suggesting that melatonin may not be directly
involved in the regulation of the photopic ERGs. Surprisingly, we
observed that circadian regulation in the photopic ERG was absent
in MT1
2/2 mice (Figure 3D), indicating that in melatonin-
proficientmiceMT1 receptorsignalingisnecessaryforthe circadian
regulation of the ERGs. A possible explanation for this unexpected
result may be found in the possibility that elimination of the MT1
receptor affects the circadian regulation in the retinal dopaminergic
system. As shown in Figure 5 A–C, removal of the MT1 receptors
did not affect the number of dopaminergic neurons, nor did it affect
the levels of DA and DOPAC or the circadian regulation of DA and
DOPAC. Therefore, the loss of circadian regulation in the photopic
ERGs observed in MT1
2/2 mice is not a consequence of the loss in
the circadian regulation of DA and DOPAC. Although these results
may appear surprising, they are not completely unexpected since
circadian regulation of DA and DOPAC is abolished in melatonin-
deficient mice [11,12], and therefore it is unlikely that the circadian
regulation of the photopic ERGs in melatonin-deficient mice is
driven by the circadian regulation of the retinal dopaminergic
system. However, it also possible that an unknown factor, rather
than melatonin, may be responsible for such a result. Future studies
using MT1
2/2 in melatonin deficient background may help to
explain these apparently inconsistent results.
A previous investigation has shown that removal of melanopsin
may affect the circadian regulation of the photic ERG [22].
Surprisingly, we observed that removal of the MT1 receptors
produce similar results on the circadian regulation of the photic
ERG, thus suggesting that melatonin may affect the circadian
regulation of the photic ERG by acting on MT1 receptors present
on the ipRGCs.
In conclusion our studies show that MT1 receptors are widely
expressed in the mouse retina, and are present on the classical
photoreceptors (i.e., the rods and cones) and on ipRGCs.
Furthermore, it appears that the presence of MT1 receptors is
required for the circadian regulation of the photic ERGs and the
circadian regulation of the retinal dopaminergic system is not
affected by the absence of MT1 receptors. Our data also suggest
that MT1 may modulate ipRGCs activity.
Materials and Methods
Animals
C3H MT1
2/2 knock-out mice homozygous for the rd1
mutation [23], generously donated by Drs. Reppert and Weaver
(University of Massachusetts Medical School), were back-crossed
with C3H/f
+/+ (WT) mice in which the rd1 mutation was removed
to produce C3H/f
+/+MT1
2/2 (MT1
2\2) as described in Baba et
al., [4]. The genotypes were determined according to the protocols
described [23]. Mice were maintained in 12 h Light: 12 h Dark
(LD) conditions (light on at 06:00 am and off at 06:00 pm) with
food and water ad libitum. All experiments conformed to the NIH
Guide on the Care and Use of Laboratory Animals, and were
approved by the Institutional Animal Care and Use Committees of
Morehouse School of Medicine (Protocol number 10-07).
Tissue preparation
3–4 month old mice were sacrificed by cervical dislocation. For
Immunofluorescent labeling of proteins in the retina, enucleated
whole eyes of WT and MT1
2/2 mice (N=4), were fixed overnight
in 4% paraformaldehyde solution in PBS, cryoprotected in 30%
sucrose solution in PBS for 48 h, and embedded in Tissue Tek
(OCT Compound). For western blots, the retina was removed
from the enucleated eyes of each genotype (N=3) through an
incision perpendicular to the anterior posterior axis of the eye and
was snap frozen in liquid nitrogen and stored at 280uC.
Characterization of MT1 receptor antibody
The novel polyclonal MT1 receptor antibody used in this study
was designed to target the C-terminal of the mouse MT1 (C-
LQVRRRVKPDNKPKLKPQD: 218–236, GenBank accession
number NC_000074), and was raised in rabbits (Pacific Immu-
nology Corp, Ramona, CA). The specificity of the antibody was
assessed by immunocytochemistry and (ICCH) and Western
Blotting (WB) techniques in WT and MT1
2/2. The antibody
was characterized with the following experiments.
Immunocytochemistry
All buffers used were based on PBS (0.1 M; pH 7.4). 10 mm
frozen sagittal retinal sections mounted on gelatin-coated glass
slides were washed in PBS (36; 10 min each). Permeabilization of
tissues was performed with 0.2% Triton X-100 in blocking buffer
containing 10% goat serum for 2 h at room temperature (RT).
Sections were incubated overnight at 4uC in serial dilutions (1:50–
1:500) of the primary MT1 antibody in 1% blocking buffer.
Sequential washing in PBS (36) was done prior to and after
incubation in secondary antibody solution (1:500; anti-Rabbit IgG
raised in Goat-FITC conjugate, Alpha Diagnostics; San Antonio
TX) for 2.5 h at RT. Sections were mounted in Vectashield
Mounting medium with DAPI (Vector Laboratories, Inc Burlin-
game CA), and imaged using an Olympus laser-scanning confocal
microscope system (IX71; Olympus, Tokyo, Japan). The specific-
ity of MT1 receptor antibody was checked by immunostaining
retinal sections of WT mice with the MT1 receptor antibody pre-
absorbed with its respective blocking peptide. Retinal sections of
MT1
2/2 mice were checked for absence of MT1 labeling, as a part
of the validation process of the antibody.
To investigate whether expression ofMT1 receptorisrestrictedto
either rods, cones, or both types of photoreceptors, retinal sections
of WT mice were double-labeled with MT1 receptor (1:500)/
Rhodopsin (1:200; rho-4D2 mouse monoclonal antibody generated
by Dr R. S. Molday, University of British Columbia, Vancouver,
Canada), MT1 receptor (1:500)/Rhodamine peanut agglutinin
(1:500; Vector Laboratories, Burlingame). The protocol for im-
munolabeling with each antibody remained the same as described
above. Sections were incubated with Texas Red-conjugated goat
anti-mouse IgG (1:500; Invitrogen Carlsbad CA) and anti-Rabbit
IgG raised in Goat-FITC conjugate, for detection of rhodopsin
and MT1 receptor respectively. Immunofluorescent staining
was examined under immunofluorescent confocal laser scanning
Melatonin Receptors in the Mouse Retina
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orescence was detected in green (FITC) or red (Texas Red,
Rhodamine). Yellow color represented colocalization of the two
antigens. Photomicrographs were prepared using Olympus Fluo-
view Fv300 (version 4.3). Colocalization of MT1 immunoreactivity
with ipRGCs was performed using a well characterized melanopsin
antibody [24] kindly donated by Dr. I. Provencio (University of
Virginia, Charlottesville, VA) and with FITC conjugated MT1
primary antibody (1:50).
Western Blot
All reagents for western blot analysis were purchased from Bio-
RadLaboratories(Hercules,CA,USA)unlessmentionedotherwise.
Six retinas of each genotype (WT and MT1
2/2respectively) were
used forextraction of retinal proteinin 250 ml of lysisbuffer(0.15 M
NaCl, 2 mM EDTA, 0.15% Triton X-100 and protease inhibitor
cocktail). Protein concentration was measured by Bradford assay
[25]. 30 mg of linearized retinal proteins were separated by
electrophoresis on a 12% Tris-HCl precast mini gel (Bio-Rad
Laboratories, Hercules, CA) under reduced conditions and was
subsequently electro-transferred (200 mA; 1 h) onto nitrocellulose
membranes (0.8 mm pore size; Bio-Rad Laboratories; Hercules
CA). The membrane was blocked in 5% skim milk solution in Tris
buffered saline (TBS) containing 0.1% Tween-20 (TBST) for 2 h at
RT followed by overnight incubation at 4uC in anti-MT1 antibody
solution (1:500 in blocking buffer). The membrane thoroughly
rinsed in TBST buffer was now incubated (2 h at RT) in HRP-
conjugated goat anti-rabbit IgG solution in TBST (1:5000),
processed for chemiluminescent reaction (3 min in ECL), then
developed on a film. Specificity of the antibody was checked by
relabeling the stripped membrane (using Restore
TM stripping
buffer; Thermo Scientific, Rockford IL) with MT1 receptor
antibody pre-absorbed with its specific peptide. a-tubulin was used
as internal/loading control.
Electroretinography
Miceweremaintained inconstant darkness(DD)for18and30 h,
and then were anesthetized with ketamine (80 mg/kg) and xylazine
(16 mg/kg). The pupils were dilated with 1% atropine and 2.5%
phenylephrine (Sigma, St. Louis, MO, USA), and mice were placed
on a regulatedheating pad setat 37uC with feedback from the rectal
temperature probe. The eye was lubricated withsaline solution, and
a contact lens type electrode (LKC Technologies model:
N1530NNC) was topically applied on the cornea. A needle
reference was inserted in other side of cheek, and the ground
needle was inserted into the base of tail. All preparation of ERG
recordings was conducted under red dim light (,3 lux, 15W Kodak
safe lamp filter 1A, Eastman Kodak, Rochester, NY, USA).
All electrodes were connected to a Universal DC Amplifier
(LKC Technologies model UBA-4200) and bands were filtered
from 0.3 to 500 Hz. Data were recorded and analyzed by EM for
Windows (ver. 8.2.1, LKC Technologies). Core body temperature
was maintained in 37uC by a feedback temperature control system
(FHC inc., Bowdoin, ME) during whole ERG recording. In the
dark-adapted ERG protocol, seven series of flash intensity between
from 0.03 to 6.28 cd*s/m
2 were presented to the mouse eye.
Flashes were generated by 530-nm green LEDs in a Ganzfeld
illuminator (LKC Technologies), and intervals of flashes increased
from 0.612 to 30 s as intensity of the flashes increased. Responses
of 3–10 flashes were averaged to generate a waveform for each
step of light intensity, and a-wave and b-wave of ERG
measurement were analyzed from the trace of wave forms.
To measure the photopic ERG mice were placed in a Ganzfeld
illuminator and cone-associated activity was isolated by saturating
rods with 63 cd*s/m
2 of white background light. The four series of
consecutive 10 white flashes (79.06 cd*s/m
2) were introduced at
2.5 min, 5 min, 10 min, and 15 min during the background light
exposure. Background light was left on for 15 min while photopic
ERGs records were measured [4]. The traces of the ERG were
averaged and stored on a computer for later analysis. The
amplitude of the b-wave was measured from the trough of the a-
wave to the peak of the b-wave or, if no a-wave was present, from
the baseline to the b-wave peak. The spectral composition and
irradiance of the light was monitored by a radio-spectrophotom-
eter (USB 2000, Ocean Optics, Dunedin, FL).
Dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC)
analysis by high-performance liquid chromatography
with colometric detection
Mice were maintained in a 12-h light/12-h dark cycle, with
lights on from zeitgeber time (ZT) 0 to ZT 12, then maintained in
total darkness (24 h per day) for 2–3 days before dissection.
Animals were euthanized by cervical dislocation and the eyeballs
were explanted. Then a small cut (1–2 mm) was performed at the
level of the ora serrata, the lens was removed and the retina was
obtained by gently squeezing the eyeball. The retinas were
immediately frozen and then stored at 280uC. All manipulations
on mice and tissues under conditions of darkness were performed
under dim red light (15W Kodak safe lamp filter 1A). Levels of
dopamine and DOPAC in mouse retina were determined by ion-
pair reversed-phase high-performance liquid chromatography
(HPLC) with colometric detection (guard cell set at 0.6 V, and
colometric analytical cell set at 0.3 V) as described by Pozdeyev
et al. [13]. Retinas were homogenized in 100 ml of 0.2 N HClO4
containing 0.01% of sodium metabisulfite and 25 ng/ml of
internal standard 3,4-dihydroxybenzylamine hydrobromide. After
centrifugation at 15,0006 g for 10 min, an 80 ml aliquot of
supernatant was analyzed. The separation was performed on an
Ultrasphere ODS 25064.6 mm column, 5 mm (Beckman Coulter,
Fullerton, CA, USA) with a mobile phase containing 0.1 M
sodium phosphate, 0.1 mM EDTA, 0.35 mM sodium octyl
sulfate, 5.5% acetonitrile (vol/vol), pH 2.7. External standards of
dopamine and DOPAC were analyzed in each experiment.
Finally, to determine whether removal of MT1 receptors affects
the number of dopaminergic neurons in the retinas from WT and
MT1
2/2 mice, retinal samples from both strains were stained as whole
mounts with a tyrosine hydroxylase (TH) antibody (Chemicon,
T e m e c u l a ,C A ) .T H - p o s i t i v en e u r o n sw e r er e v e a l e dw i t ha nA l e x a
568-conjugated secondary antibody and imaged with a Leica SP2
confocal microscope using a 206objective (HC PL APO 206/0.70).
Montages of tile images covering the whole retinal surface were
obtained acquiring TH-positive cell stacks of 10 microns and collapsing
in a maximal projection. TH-positive neurons were counted by means
of a Metamorph image analysis routine. Statistical analysis was
performed using one-way ANOVA (p,0.05 and p,0.01).
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